Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes(1)

The apoC-III proteoform containing two sialic acid residues (apoC-III(2)) has different in vitro effects on lipid metabolism compared with asialylated (apoC-III(0)) or the most abundant monosialylated (apoC-III(1)) proteoforms. Cross-sectional and longitudinal associations between plasma apoC-III pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Lipid Res
Autors principals: Koska, Juraj, Yassine, Hussein, Trenchevska, Olgica, Sinari, Shripad, Schwenke, Dawn C., Yen, Frances T., Billheimer, Dean, Nelson, Randall W., Nedelkov, Dobrin, Reaven, Peter D.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2016
Matèries:
Patient-Oriented and Epidemiological Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847634/
https://ncbi.nlm.nih.gov/pubmed/26945091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P064816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars